Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

GlobalData, June 2011, Pages: 131

Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData’s new report, “Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global neurostimulation devices market. The report provides market landscape, competitive landscape and market trends information on the neurostimulation devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Cortical Stimulators.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2010.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within neurostimulation devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, St. Jude Medical, Boston Scientific Corporation and Cyberonics.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the neurostimulation devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the neurostimulation devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global neurostimulation devices market and the factors shaping it.

1 Table of contents
1 Table of contents
1.1 List of Tables
1.2 List of Figures
2 Introduction and Overview
2.1 Report Guidance
3 Disease Overview
3.1 Disease Overview - Chronic Pain
3.1.1 Introduction
3.1.2 Causes of Chronic Pain
3.1.3 Signs and Symptoms
3.1.4 Treatment
3.1.5 Epidemiology
3.2 Disease Overview - Parkinson’s Disease
3.2.1 Introduction
3.2.2 Causes of Parkinson’s Disease
3.2.3 Signs and Symptoms
3.2.4 Treatment
3.2.5 Epidemiology
3.3 Disease Overview - Epilepsy
3.3.1 Introduction
3.3.2 Causes of Epilepsy
3.3.3 Signs and Symptoms
3.3.4 Treatment
3.3.5 Epidemiology
4 Neurostimulation Devices Overview
4.1 Technology Overview
4.1.1 Introduction
4.1.2 Types of Neurostimulation Systems
4.1.3 Applications of Neurostimulation Devices
4.1.4 Neurostimulation Devices, Market Segmentation
5 Neurostimulation Devices - Global Market Characterization
5.1 Neurostimulation Devices Market, Global, Revenue ($m), Historic, 2003-2010
5.2 Neurostimulation Devices Market, Global, Revenue ($m), Forecast, 2010-2017
5.3 Neurostimulation Device, Key Trends
5.3.1 Application of Neurostimulation Technology for the Treatment of New Indications
5.3.2 Neurostimulation Devices Market is Witnessing Increasing Innovation
5.3.3 Technological Advances such as Increased Battery Life have led to an Increase in the Adoption of Neurostimulation Devices
5.4 Neurostimulation Devices, Market Dynamics
5.4.1 Market Drivers
5.4.2 Market Restraints
5.5 Neurostimulation Devices, Key Opportunities and Unmet Needs
5.5.1 Opportunities
5.5.2 Unmet Needs
6 Global Neurostimulation Devices Market: Segment Analysis
6.1 Spinal Cord Stimulators, Market Characterization
6.1.1 Spinal Cord Stimulators Market, Revenue ($m), Historic, 2003-2010
6.1.2 Spinal Cord Stimulators Market, Revenue ($m), Forecast, 2010-2017
6.1.3 Spinal Cord Stimulators, Market Dynamics
6.2 Deep Brain Stimulators, Market Characterization
6.2.1 Deep Brain Stimulators Market, Revenue ($m), Historic, 2003 - 2010
6.2.2 Deep Brain Stimulators Market, Revenue ($m), Forecast, 2010-2017
6.2.3 Deep Brain Stimulators, Market Dynamics
6.3 Sacral Nerve Stimulators, Market Characterization
6.3.1 Sacral Nerve Stimulators Market, Revenue ($m), Historic, 2003-2010
6.3.2 Sacral Nerve Stimulators Market, Revenue ($m), Forecast, 2010-2017
6.3.3 Sacral Nerve Stimulators, Market Dynamics
6.4 Vagus Nerve Stimulators, Market Characterization
6.4.1 Vagus Nerve Stimulators Market, Revenue ($m), Historic, 2003-2010
6.4.2 Vagus Nerve Stimulators Market, Revenue ($m), Forecast, 2010-2017
6.4.3 Vagus Nerve Stimulators, Market Dynamics
6.5 Cortical Stimulators, Market Characterization
6.5.1 Cortical Stimulators Market, Revenue ($m), Historic, 2003-2010
6.5.2 Cortical Stimulators Market, Revenues ($m), Forecast, 2010-2017
6.5.3 Cortical Stimulators, Market Dynamics
7 Neurostimulation Devices Market, by Country, Revenue ($m), 2003-2017
7.1 Neurostimulation Devices Market, The US, Revenue ($m), By Segment, Historic, 2003-2010
7.2 Neurostimulation Devices Market, The US, Revenue ($m), By Segment, Forecast, 2010-2017
7.3 Neurostimulation Devices Market, Canada, Revenue ($m), By Segment, Historic, 2003-2010
7.4 Neurostimulation Devices Market, Canada, Revenue ($m), By Segment, Forecast, 2010–2017
7.5 Neurostimulation Devices Market, The UK, Revenue ($m), By Segment, Historic, 2003–2010
7.6 Neurostimulation Devices Market, The UK Revenue ($m), By Segment, Forecast, 2010–2017
7.7 Neurostimulation Devices Market, Germany, Revenue ($m), By Segment, Historic, 2003–2010
7.8 Neurostimulation Devices Market, Germany, Revenue ($m), By Segment, Forecast, 2010–2017
7.9 Neurostimulation Devices Market, France, Revenue ($m), By Segment, Historic, 2003-2010
7.10 Neurostimulation Devices Market, France, Revenue ($m), By Segment, Forecast, 2010–2017
7.11 Neurostimulation Devices Market, Italy, Revenue ($m), By Segment, Historic, 2003–2010
7.12 Neurostimulation Devices Market, Italy, Revenue ($m), By Segment, Forecast, 2010–2017
7.13 Neurostimulation Devices Market, Spain, Revenue ($m), By Segment, Historic, 2003-2010
7.14 Neurostimulation Devices Market, Spain, Revenue ($m), By Segment, Forecast, 2010-2017
7.15 Neurostimulation Devices Market, Japan, Revenue ($m), By Segment, Historic, 2003-2010
7.16 Neurostimulation Devices Market, Japan, Revenue ($m), By Segment, Forecast, 2010-2017
7.17 Neurostimulation Devices Market, China, Revenue ($m), By Segment, Historic, 2003-2010
7.18 Neurostimulation Devices Market, China, Revenue ($m), By Segment, Forecast, 2010-2017
7.19 Neurostimulation Devices Market, India, Revenue ($m), By Segment, Historic, 2003-2010
7.20 Neurostimulation Devices Market, India, Revenue ($m), By Segment, Forecast, 2010-2017
7.21 Neurostimulation Devices Market, Australia, Revenue ($m), By Segment, Historic, 2003-2010
7.22 Neurostimulation Devices Market, Australia, Revenue ($m), By Segment, Forecast, 2010-2017
7.23 Neurostimulation Devices Market, Brazil, Revenue ($m), By Segment, Historic, 2003-2010
7.24 Neurostimulation Devices Market, Brazil, Revenue ($m), By Segment, Forecast, 2010-2017
8 Neurostimulation Devices Market - Competitive Landscape
8.1 Neurostimulation Devices Market, Key Company Share (%), 2010
8.2 Neurostimulation Devices Market, Key Market Participants
8.2.1 Medtronic, Inc.
8.2.2 St. Jude Medical
8.2.3 Boston Scientific Corporation
8.2.4 Cyberonics, Inc.
9 Neurostimulation Devices Market - Key Marketed Products
9.1 PrimeAdvanced Neurostimulator (Medtronic, Inc.)
9.1.1 Product Description
9.1.2 Product Features
9.2 Activa Portfolio of DBS systems (Medtronic, Inc.)
9.2.1 Product Description
9.2.2 Product Features
9.3 Precision Plus SCS System (Boston Scientific Corporation)
9.3.1 Product Description
9.3.2 Product Features
9.4 Brio Rechargeable IPG (St. Jude Medical)
9.4.1 Product Description
9.4.2 Product Features
9.5 Eon-Mini Rechargeable IPG system (St. Jude Medical)
9.5.1 Product Description
9.5.2 Product Features
10 Neurostimulation Devices Market - Strategic Pipeline Assessment
10.1 Pipeline Products Assessment for Neurostimulation Devices by Development Stage, Global, 2010
10.2 Neurostimulation Devices - Profiles of Key Pipeline Products Under Clinical Development
10.2.1 Active Implantable Device- Parkinson’s Disease
10.2.2 Balance System
10.2.3 Biocompatible Neural Electrode
10.2.4 Bioness Battery Powered Microstimulator
10.2.5 CardioFit System
10.2.6 CR Brain
10.2.7 Deep TMS H System
10.2.8 Enterra-Obesity
10.2.9 Intercept Epilepsy Control System
10.2.10 Ischemic Stroke System
10.2.11 Libra Deep Brain Stimulation System - Depression
10.2.12 Neurostep
10.2.13 Noninvasive Device - Sensory Enhancement Technology
10.2.14 Occipital Nerve Stimulation System
10.2.15 Pain Therapy Device
10.2.16 PrimeADVANCED- Heart Failure
10.2.17 Resolve Stimulator and Proximity Electrode
10.2.18 RNS System
10.2.19 ScyFIX 700 Therapy
10.2.20 Transcranial Magnetic Stimulation Device
10.2.21 Traxon Spinal Cord Repair Stimulation System
10.2.22 Vercise DBS System
11 Neurostimulation Devices Market: Deals Landscape
11.1 Neurostimulation Devices Market, M&A Landscape
11.1.1 Key Acquisitions
11.2 Neurostimulation Devices Market, Partnership Deals
11.2.1 Key Partnership Deals
12 Appendix
12.1 Market Definitions
12.1.1 Neurostimulation Devices
12.2 Acronyms
12.3 Sources
12.4 Research Methodology
12.4.1 Secondary Research
12.4.2 Primary Research
12.4.3 Models
12.4.4 Forecasts
12.4.5 Expert Panel
12.5 Consulting
12.6 Contact Us
12.7 Disclaimer

1.1 List of Tables
Table 1: Deep Brain Stimulators, Key Marketed Products
Table 2: Spinal Cord Stimulators, Key Marketed Products
Table 3: Neurostimulation Devices Market, Global, Revenue ($m), 2003-2010
Table 4: Neurostimulation Devices Market, Global, Revenue ($m), 2010-2017
Table 5: Pipeline Products In-Development for New Indications
Table 6: Population Aged 65 Years and Over, Global, %, 2010
Table 7: Neurostimulation Devices Market, Global, PE/VC Deals, 2006-2010
Table 8: Neurostimulation Devices, Global, Average Selling Price ($), 2010
Table 9: Spinal Cord Stimulators Market, Global, Revenue ($m), 2003-2010
Table 10: Spinal Cord Stimulators Market, Global, Revenue ($m), 2010-2017
Table 11: Deep Brain Stimulators Market, Global, Revenue ($m), 2003-2010
Table 12: Deep Brain Stimulators Market, Global, Revenue ($m), 2010-2017
Table 13: DBS Pipeline Products
Table 14: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2003-2010
Table 15: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2010-2017
Table 16: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2003-2010
Table 17: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2010-2017
Table 18: Cortical Stimulators Market, Global, Revenue ($m), 2003-2010
Table 19: Cortical Stimulators Market, Global, Revenue ($m), 2010-2017
Table 20: Neurostimulation Devices Market, The US, Revenue ($m), 2003-2010
Table 21: Neurostimulation Devices Market, The US, Revenue ($m), 2010-2017
Table 22: Neurostimulation Devices Market, Canada, Revenue ($m), 2003-2010
Table 23: Neurostimulation Devices Market, Canada, Revenue ($m), 2010-2017
Table 24: Neurostimulation Devices Market, The UK, Revenue ($m), 2003-2010
Table 25: Neurostimulation Devices Market, The UK, Revenue ($m), 2010-2017
Table 26: Neurostimulation Devices Market, Germany, Revenue ($m), 2003-2010
Table 27: Neurostimulation Devices Market, Germany, Revenue ($m), 2010-2017
Table 28: Neurostimulation Devices Market, France, Revenue ($m), 2003-2010
Table 29: Neurostimulation Devices Market, France, Revenue ($m), 2010-2017
Table 30: Neurostimulation Devices Market, Italy, Revenue ($m), 2003-2010
Table 31: Neurostimulation Devices Market, Italy, Revenue ($m), 2010-2017
Table 32: Neurostimulation Devices Market, Spain, Revenue ($m), 2003-2010
Table 33: Neurostimulation Devices Market, Spain, Revenue ($m), 2010-2017
Table 34: Neurostimulation Devices Market, Japan, Revenue ($m), 2003-2010
Table 35: Neurostimulation Devices Market, Japan, Revenue ($m), 2010-2017
Table 36: Neurostimulation Devices Market, China, Revenue ($m), 2003-2010
Table 37: Neurostimulation Devices Market, China, Revenue ($m), 2010-2017
Table 38: Neurostimulation Devices Market, India, Revenue ($m), 2003-2010
Table 39: Neurostimulation Devices Market, India, Revenue ($m), 2010-2017
Table 40: Neurostimulation Devices Market, Australia, Revenue ($m), 2003-2010
Table 41: Neurostimulation Devices Market, Australia, Revenue ($m), 2010-2017
Table 42: Neurostimulation Devices Market, Brazil, Revenue ($m), 2003-2010
Table 43: Neurostimulation Devices Market, Brazil, Revenue ($m), 2010-2017
Table 44: Global Neurostimulation Devices Market, Company Share, Revenue ($m), 2010
Table 45: Medtronic, Neurostimulators, Marketed Products
Table 46: Medtronic, Neurostimulators, Pipeline Products
Table 47: St. Jude Medical, Neurostimulators, Marketed Products
Table 48: St. Jude Medical, Neurostimulators, Pipeline Products
Table 49: Boston Scientific, Neurostimulators, Pipeline Products
Table 50: Cyberonics, Neurostimulators, Marketed Products
Table 51: Cyberonics, Neurostimulators, Pipeline Products
Table 52: PrimeAdvanced Neurostimulator, Features and Benefits
Table 53: Activa DBS systems, Features and Benefits
Table 54: Precision Plus SCS system, Features and Benefits
Table 55: Brio Rechargeable IPG, Features and Benefits
Table 56: Eon Mini Rechargeable IPG system, Features and Benefits
Table 57: Balance System, Clinical Trial
Table 58: Bioness Battery Powered Microstimulator, Clinical Trial
Table 59: CardioFit System, Clinical Trial
Table 60: CardioFit System, Clinical Trial
Table 61: Deep TMS H System, Clinical Trial
Table 62: Deep TMS H System, Clinical Trial
Table 63: Deep TMS H System, Clinical Trial
Table 64: Deep TMS H System, Clinical Trial
Table 65: Deep TMS H System, Clinical Trial
Table 66: Enterra-Obesity, Clinical Trial
Table 67: Intercept Epilepsy Control System, Clinical Trial
Table 68: Ischemic Stroke System, Clinical Trial
Table 69: Ischemic Stroke System, Clinical Trial
Table 70: Libra Deep Brain Stimulation System, Clinical Trial
Table 71: Neurostep, Clinical Trial
Table 72: Non-invasive Device - Sensory Enhancement, Clinical Trial
Table 73: Occipital Nerve Stimulation System, Clinical Trial
Table 74: Occipital Nerve Stimulation System, Clinical Trial
Table 75: Pain Therapy Device, Clinical Trial
Table 76: PrimeADVANCED-Heart Failure, Clinical Trial
Table 77: Resolve Stimulator and Proximity Electrode, Clinical Trial
Table 78: Resolve Stimulator and Proximity Electrode, Clinical Trial
Table 79: RNS System, Clinical Trial
Table 80: RNS System, Clinical Trial
Table 81: RNS System, Clinical Trial
Table 82: ScyFIX 700 Therapy, Clinical Trial
Table 83: ScyFIX 700 Therapy, Clinical Trial
Table 84: ScyFIX 700 Therapy, Clinical Trial
Table 85: ScyFIX 700 Therapy, Clinical Trial
Table 86: ScyFIX 700 Therapy, Clinical Trial
Table 87: Transcranial Magnetic Stimulation (TMS) Device, Clinical Trial
Table 88: Traxon Spinal Cord Repair Stimulation System, Clinical Trial
Table 89: Vercise DBS System, Clinical Trial
Table 90: Neurostimulation Devices Market, Global, Deals Overview, 2006-2011
Table 91: Neurostimulation Devices Market, Global, Partnership Landscape, 2006-2010

1.2 List of Figures
Figure 1: Classification of Pain
Figure 2: Types of Neurostimulation Devices
Figure 3: Neurostimulation Devices Market, Global, Revenue ($m), 2003-2010
Figure 4: Neurostimulation Devices Market, Global, Revenue ($m), 2010-2017
Figure 5: Indications of Neurostimulation Devices
Figure 6: Neurostimulation Devices, Closed Loop System
Figure 7: Neurostimulation Devices Market, Global, PE/VC Deals, 2006-2010
Figure 8: Risks Associated with Neurostimulation Devices
Figure 9: Spinal Cord Stimulators Market, Global, Revenue ($m), 2003-2010
Figure 10: Spinal Cord Stimulators Market, Global, Revenue ($m), 2010-2017
Figure 11: Deep Brain Stimulators Market, Global, Revenue ($m), 2003-2010
Figure 12: Deep Brain Stimulators Market, Global, Revenue ($m), 2010-2017
Figure 13: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2003-2010
Figure 14: Sacral Nerve Stimulators Market, Global, Revenue ($m), 2010-2017
Figure 15: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2003-2010
Figure 16: Vagus Nerve Stimulators Market, Global, Revenue ($m), 2010-2017
Figure 17: Cortical Stimulators Market, Global, Revenue ($m), 2003-2010
Figure 18: Cortical Stimulators Market, Global, Revenue ($m), 2010-2017
Figure 19: Neurostimulation Devices Market, The US, Revenue ($m), 2003-2010
Figure 20: Neurostimulation Devices Market, The US, Revenue ($m), 2010-2017
Figure 21: Neurostimulation Devices Market, Canada, Revenue ($m), 2003-2010
Figure 22: Neurostimulation Devices Market, Canada, Revenue ($m), 2010-2017
Figure 23: Neurostimulation Devices Market, The UK, Revenue ($m), 2003-2010
Figure 24: Neurostimulation Devices Market, The UK, Revenue ($m), 2010-2017
Figure 25: Neurostimulation Devices Market, Germany, Revenue ($m), 2003-2010
Figure 26: Neurostimulation Devices Market, Germany, Revenue ($m), 2010-2017
Figure 27: Neurostimulation Devices Market, France, Revenue ($m), 2003-2010
Figure 28: Neurostimulation Devices Market, France, Revenue ($m), 2010-2017
Figure 29: Neurostimulation Devices Market, Italy, Revenue ($m), 2003-2010
Figure 30: Neurostimulation Devices Market, Italy, Revenue ($m), 2010-2017
Figure 31: Neurostimulation Devices Market, Spain, Revenue ($m), 2003-2010
Figure 32: Neurostimulation Devices Market, Spain, Revenue ($m), 2010-2017
Figure 33: Neurostimulation Devices Market, Japan, Revenue ($m), 2003-2010
Figure 34: Neurostimulation Devices Market, Japan, Revenue ($m), 2010-2017
Figure 35: Neurostimulation Devices Market, China, Revenue ($m), 2003-2010
Figure 36: Neurostimulation Devices Market, China, Revenue ($m), 2010-2017
Figure 37: Neurostimulation Devices Market, India, Revenue ($m), 2003-2010
Figure 38: Neurostimulation Devices Market, India, Revenue ($m), 2010-2017
Figure 39: Neurostimulation Devices Market, Australia, Revenue ($m), 2003-2010
Figure 40: Neurostimulation Devices Market, Australia, Revenue ($m), 2010-2017
Figure 41: Neurostimulation Devices Market, Brazil, Revenue ($m), 2003-2010
Figure 42: Neurostimulation Devices Market, Brazil, Revenue ($m), 2010-2017
Figure 43: Global Neurostimulation Devices Market, Company Share (%), 2010
Figure 44: Neurostimulation Devices Market, Medtronic, SWOT Analysis
Figure 45: Neurostimulation Devices Market, St. Jude Medical, SWOT Analysis
Figure 46: Neurostimulation Devices Market, Boston Scientific, SWOT Analysis
Figure 47: Neurostimulation Devices Market, Cyberonics, SWOT Analysis
Figure 48: Neurostimulation Devices, Pipeline Products, By Development Stage
Figure 49: Neurostimulation Devices Market, Global, Deals Overview, 2006-2011
Figure 50: Neurostimulation Devices Market, Global, M&A Landscape

GlobalData’s new report, “Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global neurostimulation devices market. The report provides market landscape, competitive landscape and market trends information on the neurostimulation devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

The Global Neurostimulation Devices Market is Forecast to Reach $4.7 Billion by 2017

The global neurostimulation devices market was valued at $1.8 billion in 2010 and is expected to grow at a compound annual growth rate (CAGR) of 14% to reach $4.7 billion by 2017. The spinal cord stimulation (SCS) devices market is the largest segment of the neurostimulation devices market. The SCS devices market accounted for $1,089m in 2010 and is estimated to grow at a CAGR of 15% to reach $2,819m in 2017. The neurostimulation devices market is poised for rapid growth as a lot of research is being undertaken on neurostimulation therapy for the treatment of various indications, such as Parkinson’s disease, chronic pain, epilepsy, and depression. The introduction of more technologically advanced neurostimulation devices and the growing disease prevalence and incidence is expected to drive growth in the future.

The rise in research and development (R&D) in this segment, as well as rising healthcare spending, will further encourage innovation in this field. The increasing elderly population and consequent rise in disease incidence will compound the growing demand for newer and more advanced neurostimulation devices. The neurostimulation devices segment has a strong pipeline, with a number of companies engaged in the development of innovative neurostimulator products. Support from regulatory bodies including the FDA (Food and Drug Administration) will also drive investment in the neurostimulation devices market, which will result in the development of improved and more efficient neurostimulators.

Medtronic, Inc.
St. Jude Medical
Boston Scientific Corporation
Cyberonics, Inc.

Customers who bought this item also bought

• Neurostimulation - Advanced Technologies and Global Market (2009 - 2014)
• Gene Amplification Technologies - Global Strategic Business Report
• Biotechnology Instrumentation - Global Strategic Business Report
• Molecular Cytogenetics - Global Strategic Business Report
• Proteomics - Global Strategic Business Report
• Global Biopharmaceutical Market Report & Forecast (2012-2017)
• Electronic Access Control Systems - Global Strategic Business Report
• Biomaterials – A Global Market Overview
• RNA Interference (RNAi) - Global Strategic Business Report
• Biotechnology Reagents - Global Strategic Business Report